BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $46,000 | +53.3% | 568 | +42.0% | 0.01% | +125.0% |
| Q1 2019 | $30,000 | -90.7% | 400 | -90.2% | 0.00% | -93.3% |
| Q3 2018 | $321,000 | +3.2% | 4,100 | -19.6% | 0.06% | -15.5% |
| Q2 2018 | $311,000 | +498.1% | 5,100 | +750.0% | 0.07% | +446.2% |
| Q1 2018 | $52,000 | -55.9% | 600 | -64.7% | 0.01% | -50.0% |
| Q3 2017 | $118,000 | -82.2% | 1,700 | -89.8% | 0.03% | -65.8% |
| Q1 2017 | $664,000 | +538.5% | 16,604 | +345.9% | 0.08% | +484.6% |
| Q4 2016 | $104,000 | – | 3,724 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |